Cervical cancer is the most common gynecological malignant tumor worldwide, and it
remains a major health problem among women, especially in developing countries. Despite …

Purpose Human papillomavirus (HPV) is the most prevalent sexually transmitted disease
and a known cause of many cancers. Previous research explored HPV‐associated (HPVa) …

Background Differences in human papillomavirus (HPV) prevalence among males and
females have been reported. Using the 2013–2014 National Health and Nutrition …

Aim To explore the role of vaginal microecology in cervical cancer, so as to increase the
understanding of cervical cancer and lay a foundation for future large‐sample clinical trials …

Prophylactic vaccines against human papillomavirus (HPV) have proven efficacy in those
who have not been infected by the virus. However, they do not benefit patients with …

Oropharyngeal cancer (OPC) is currently the most frequent human papillomavirus (HPV)–
related malignancy in high-income countries. Oral HPV16 infection is the cause of HPV …

Integration of high-risk HPV genomes into cellular chromatin has been confirmed to promote
cervical carcinogenesis, with HPV16 being the most prevalent high-risk type. Herein, we …

All EU countries have introduced Human papilloma virus (HPV) vaccination for adolescent
girls and many countries are expanding the strategy to include adolescent boys. There is …

Human papillomavirus (HPV) infection is one of the most common viral infections in sexually
active population worldwide, and is the main cause of cervical cancer, which is the fourth …

We estimated the overall and type‐specific prevalence of human papillomavirus (HPV) and
p16 overexpression in vaginal cancer and vaginal intraepithelial neoplasia (VaIN). We …